Literature DB >> 1977035

Prevention of Pneumocystis carinii pneumonitis in AIDS patients with weekly dapsone.

W T Hughes, W Kennedy, M Dugdale, M A Land, D S Stein, J J Weems, S Palte, D Lancaster, S Gidan-Kovnar, R E Morrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1977035     DOI： 10.1016/0140-6736(90)92533-n

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Clinical and economic aspects of prophylaxis and treatment of Pneumocystis carinii pneumonia.

Authors:  K A Freedberg
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

2.  Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children.

Authors:  M Mirochnick; E Cooper; K McIntosh; J Xu; J Lindsey; D Jacobus; L Mofenson; J L Sullivan; W Dankner; L M Frenkel; S Nachman; D W Wara; D Johnson; V R Bonagura; M H Rathore; C K Cunningham; J McNamara
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

3.  Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.

Authors:  J Falloon; J Lavelle; D Ogata-Arakaki; A Byrne; A Graziani; A Morgan; M A Amantea; K Ownby; M Polis; R T Davey
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

Review 4.  Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations.

Authors:  M Barry; S Gibbons; D Back; F Mulcahy
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

5.  Population pharmacokinetics of dapsone administered biweekly to human immunodeficiency virus-infected patients.

Authors:  G Gatti; M Merighi; J Hossein; S Travaini; R Casazza; M Karlsson; M Cruciani; D Bassetti
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

6.  Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.

Authors:  L E Bermudez; C B Inderlied; P Kolonoski; M Petrofsky; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

7.  Pharmacokinetics of dapsone in human immunodeficiency virus-infected children.

Authors:  G Gatti; A Loy; R Casazza; F Miletich; M Cruciani; D Bassetti
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.